Journal of Pain Management & Medicine

Department of Anesthesia, Critical Care and Pain Medicine, University of Minnesota, Twin Cities,MN, USA

Biography

Dr. Schultz is the founder and Chief Executive Officer of Nura Pain Clinics (formerly MAPS Medical Pain Clinics). He has been a full-time interventional pain specialist since 1995 and is an adjunct professor in the Department of Anesthesiology at the University of Minnesota. He is a certified board examiner for ABIPP. He is a former board member and past president of the American Society of Interventional Pain Physicians (ASIPP) and is currently Executive Director of the Minnesota Society of Interventional Pain Physicians (the MN chapter of ASIPP). 

Publications

• Mini Review   
  Discussion of Targeted Drug Delivery Article
  Author(s): David Schultz*, Jonathan M. Hagedorn, Scott Stayner and Caitlin Bakke
  
  Targeted Drug Delivery (TDD) is commonly used for the management of patients with intractable pain. Past studies have proven efficacy in pain relief and reduction in opioid use and cost-effectiveness in long-term pain management. There are few studies investigating satisfaction amongst patients with implanted pain pumps that are managed with targeted intrathecal medications. We published a study in Neuromodulation in April of 2020 describing patient satisfaction with TDD in single medical practice for patients implanted with pain pumps for relief of intractable chronic benign pain. Six hundred and ten active TDD patients were identified, and an anonymous 18-question survey was administered to determine satisfaction with TDD therapy. Four hundred and forty-three patients (74% of the active pump population) completed the survey. Most patients reported improvement i.. View more»
  

  DOI: 10.35248/2684-1320.21.7.152

  Abstract HTML PDF